12-2550019-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000719.7(CACNA1C):​c.1467C>T​(p.Cys489Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000175 in 1,604,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0120

Publications

1 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 12-2550019-C-T is Benign according to our data. Variant chr12-2550019-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 527090.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.012 with no splicing effect.
BS2
High AC in GnomAd4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.1557C>T p.Cys519Cys synonymous_variant Exon 10 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.1632C>T p.Cys544Cys synonymous_variant Exon 11 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.1557C>T p.Cys519Cys synonymous_variant Exon 10 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.1557C>T p.Cys519Cys synonymous_variant Exon 10 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.1557C>T p.Cys519Cys synonymous_variant Exon 10 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.1557C>T p.Cys519Cys synonymous_variant Exon 10 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.1542C>T p.Cys514Cys synonymous_variant Exon 11 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.1542C>T p.Cys514Cys synonymous_variant Exon 11 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.1458C>T p.Cys486Cys synonymous_variant Exon 10 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.1467C>T p.Cys489Cys synonymous_variant Exon 10 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000480911.6 linkn.*74C>T non_coding_transcript_exon_variant Exon 8 of 27 5 ENSP00000437936.2 F5H638
CACNA1CENST00000480911.6 linkn.*74C>T 3_prime_UTR_variant Exon 8 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152146
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000216
AC:
5
AN:
231064
AF XY:
0.0000399
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000118
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000192
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000158
AC:
23
AN:
1452298
Hom.:
0
Cov.:
30
AF XY:
0.0000166
AC XY:
12
AN XY:
721434
show subpopulations
African (AFR)
AF:
0.0000900
AC:
3
AN:
33338
American (AMR)
AF:
0.00
AC:
0
AN:
43582
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25980
East Asian (EAS)
AF:
0.0000763
AC:
3
AN:
39312
South Asian (SAS)
AF:
0.0000237
AC:
2
AN:
84228
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52756
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5754
European-Non Finnish (NFE)
AF:
0.0000117
AC:
13
AN:
1107294
Other (OTH)
AF:
0.0000333
AC:
2
AN:
60054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152146
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.0000965
AC:
4
AN:
41438
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000181
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 19, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Apr 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jan 21, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
9.8
DANN
Benign
0.74
PhyloP100
0.012

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781074075; hg19: chr12-2659185; COSMIC: COSV59769373; API